Fourpath Capital Management’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$649K Sell
8,353
-297
-3% -$24.6K 0.08% 137
2026
Q2
$733K Hold
8,650
– – 0.1% 142
2026
Q1
$724K Sell
8,650
-419
-5% -$31.6K 0.1% 128
2025
Q4
$608K Hold
9,069
– – 0.08% 134
2025
Q3
$613K Hold
9,069
– – 0.09% 135
2025
Q2
$676K Hold
9,069
– – 0.11% 117
2025
Q1
$571K Hold
9,069
– – 0.1% 125
2024
Q4
$517K Hold
9,069
– – 0.1% 141
2024
Q3
$533K Buy
+9,069
New +$495K 0.1% 138

Other funds holding CTVA

Fourpath Capital Management's CTVA Position: Q3 2026 in Review

Fourpath Capital Management reduced its Corteva (CTVA) stake by 3.4% in Q3 2026, selling an estimated $24.6K and leaving 8,353 shares worth $649K. The position accounts for 0.08% of the portfolio, ranked #137.

Fourpath Capital Management first reported a position in CTVA in Q3 2024 and has held it in 9 quarters since. The position peaked at $733K in Q2 2026. 300 funds tracked by Wall St. Rank hold CTVA as of Q3 2026.

  • Fourpath Capital Management held 8,353 shares of Corteva worth $649K as of Q3 2026.
  • Fourpath Capital Management sold 297 Corteva shares in Q3 2026, an estimated $24.6K.
  • Corteva made up 0.08% of Fourpath Capital Management's portfolio in Q3 2026, its #137 holding.
  • Fourpath Capital Management first reported a position in Corteva in Q3 2024 and has held it in 9 quarters since.
  • Fourpath Capital Management's Corteva position peaked at $733K in Q2 2026.
  • 300 funds tracked by Wall St. Rank held Corteva as of Q3 2026.

Based on Fourpath Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.